Herpes Cure Advocacy (HCA) is issuing a call for individuals to serve on its Board of Directors. As an organization with a growing slate of health policy, education, and researchContinue reading "Herpes Cure Advocacy Seeks Volunteer Board Members"
New Therapeutic Strategies for Genital Herpes: NIH Initiative
The National Institute of Health (NIH) is ramping up efforts to improve treatments for genital herpes with a new funding opportunity. Current treatment options are limited, often failing to completelyContinue reading "New Therapeutic Strategies for Genital Herpes: NIH Initiative"
Early Phase 1a clinical trials show potential for long-acting antiherpetic drugs.
Assembly Biosciences announced the most exciting results of the first phase 1a clinical trial of their most advanced helicase primase inhibitor, ABI-5366 (registered as clinical trial NCT06385327). The results exceededContinue reading "Early Phase 1a clinical trials show potential for long-acting antiherpetic drugs."
3 Days. 30 hours. And only 10 minutes dedicated to Herpes.
Takeaways from the 2024 CDC STI Prevention Conference This past week I was fortunate to have the opportunity to attend the CDC STI Prevention Conference in Atlanta, Georgia! As aContinue reading "3 Days. 30 hours. And only 10 minutes dedicated to Herpes."
NEW STUDY AND ANALYSIS: Breakthrough in Understanding of Viral Infection and Neurodegenerative Disease
The COVID-19 pandemic, along with the neurological complications seen in long COVID patients, has brought renewed attention to the possible link between viral infections and neurodegenerative diseases. Although viruses likeContinue reading "NEW STUDY AND ANALYSIS: Breakthrough in Understanding of Viral Infection and Neurodegenerative Disease"
Board of Directors Statement on GSK Clinical Trial News
For Immediate Release Media Contact: Email: info@herpescureadvocacy.com P: 267-797-7139 Philadelphia, PA - Herpes Cure Advocacy has learned about the outcome of GSK’s trial of GSK3943104 which has failed to meet theContinue reading "Board of Directors Statement on GSK Clinical Trial News"
Dr. David Leib Joins Herpes Cure Advocacy Medical Advisory Board
Herpes Cure Advocacy is pleased to welcome Dr. David Leib to our Medical Advisory Board. Dr. Leib is the Chair and Professor of Microbiology and Immunology at Dartmouth Geisel SchoolContinue reading "Dr. David Leib Joins Herpes Cure Advocacy Medical Advisory Board"
News from Herpes Cure Advocacy
There is momentum in the field of new herpes diagnostics and therapies. Advocates, experts and patient advocates continue to urge public health stakeholders to advance new vaccines into clinical trialsContinue reading "News from Herpes Cure Advocacy"
Genital Herpes: Diagnosis, Testing, Treatment
Johnston C, Wald A. Genital Herpes. JAMA. 2024;332(10):835–836. doi:10.1001/jama.2024.12743 Outstanding up-to-date summary of the genital herpes virus, symptoms, testing, and treatment by two of the world’s leading herpes researchers andContinue reading "Genital Herpes: Diagnosis, Testing, Treatment"
Herpes Impact on Brain Health: New study indicates Shringix Vaccine prevents dementia
Experts insist we are at a tipping point in scientific research relating to herpesviruses impact on dementia and Alzheimer's Disease. Last month a new study from a team in AustraliaContinue reading "Herpes Impact on Brain Health: New study indicates Shringix Vaccine prevents dementia"